Semaglutide vs Tirzepatide: Which Is Better for Weight Loss and Diabetes?

Semaglutide vs Tirzepatide: Which Is Better for Weight Loss and Diabetes?

If you or someone you know is struggling with obesity or type 2 diabetes, you may have heard of two medications that are making waves in the medical world: semaglutide and tirzepatide. Both are injectable treatments that help with weight loss and blood sugar control. But which one works better? And what are the side effects?

Let’s break it down in simple terms.

What Are These Medications?

Semaglutide (sold under brand names like Wegovy and Ozempic) works by mimicking a hormone called GLP-1, which helps control appetite and blood sugar.

Tirzepatide (sold under the brand name Mounjaro) works on two hormones: GLP-1 and GIP. This dual action can lead to stronger effects on both weight and blood sugar levels.

Both are given as weekly injections and are now approved for people with obesity, with or without type 2 diabetes.

What Does the Research Say?

Researchers looked at large clinical trials that studied both drugs. Since no trial has directly compared them yet, they analyzed two similar studies:

  • STEP-1 and SURMOUNT-1: Focused on people with obesity but without diabetes.
  • STEP-2 and SURMOUNT-2: Focused on people with both obesity and type 2 diabetes.

The goal was to see how much weight people lost and how much their blood sugar (measured by HbA1c) improved after using these drugs.

Weight Loss Results

In people without diabetes:

  • Semaglutide 2.4 mg helped people lose about 15% of their body weight on average.
  • Tirzepatide 10 mg and 15 mg led to even greater weight loss: around 19% to 20% on average.

In people with type 2 diabetes:

  • Semaglutide 2.4 mg led to an average weight loss of about 9%.
  • Tirzepatide 10 mg and 15 mg resulted in 12.5% to 14% weight loss, which is about 3.5% to 5.4% more than semaglutide.

Blood Sugar Control

Among those with type 2 diabetes:

  • Semaglutide 2.4 mg reduced HbA1c by about 1.5%.
  • Tirzepatide 10 and 15 mg lowered it even more, with an extra 0.35% to 0.37% drop compared to semaglutide.

That means tirzepatide may be slightly more effective for blood sugar control as well.

What About Side Effects?

Both medications can cause digestive problems like nausea, vomiting, diarrhea, and constipation. However, the studies showed:

  • Tirzepatide 10 mg and 15 mg caused fewer stomach issues than semaglutide 2.4 mg.
  • Tirzepatide 5 mg had the least side effects among all.

This might be because tirzepatide’s second hormone (GIP) may help reduce nausea.

Why Does Tirzepatide Work Better?

There are two possible reasons:

  1. Dual hormone action: Tirzepatide targets both GLP-1 and GIP receptors. This could enhance appetite control and help the body use energy more efficiently.
  2. Higher dosage range: The strongest tirzepatide dose (15 mg) is more than six times the semaglutide dose (2.4 mg), which could explain the stronger effect.

Should You Switch From Semaglutide to Tirzepatide?

If you’re already doing well on semaglutide, there may be no need to switch. But if weight loss has stalled or side effects are hard to manage, tirzepatide might be worth considering. Always speak to your doctor before making changes.

Also, keep in mind that both medications work best when combined with lifestyle changes like diet and exercise.

Cost and Availability

Both drugs are expensive and may not be easily available in all countries yet. Tirzepatide was only recently approved for weight loss, while semaglutide has been available longer.

In India and other developing countries, access and cost will play a big role in which treatment becomes more popular.

The Bottom Line

  • Tirzepatide 10 and 15 mg appear to offer better weight loss and blood sugar control than semaglutide 2.4 mg.
  • Tirzepatide may also cause fewer digestive side effects.
  • But more direct comparisons are still needed to know for sure.

These medications are powerful tools, but they are not magic fixes. A healthy lifestyle remains the foundation of managing obesity and diabetes.

Final Thoughts

As these medications become more widely available, they offer hope to millions struggling with obesity and type 2 diabetes. Talk to your doctor about what might work best for you, and remember that small, consistent changes in your daily routine can make a big difference in the long run.

Reference: https://www.sciencedirect.com/science/article/abs/pii/S1871402125000293

Back to blog